Targeting Epitranscriptomic Proteins for Therapeutic Intervention
Author:
Affiliation:
1. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2. University of the Chinese Academy of Sciences, Beijing 100049, China
Funder
National Natural Science Foundation of China
Publisher
American Chemical Society (ACS)
Subject
Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.biochem.9b00755
Reference18 articles.
1. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
2. Grand Challenge Commentary: RNA epigenetics?
3. The birth of the Epitranscriptome: deciphering the function of RNA modifications
4. The dynamic epitranscriptome: N6-methyladenosine and gene expression control
5. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy;Acta Pharmaceutica Sinica B;2024-07
2. Targeting epitranscriptomics for novel drug development;Biochemical and Molecular Pharmacology in Drug Discovery;2024
3. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties;Journal of Medicinal Chemistry;2023-07-07
4. Research Progress on Chemical Intervention of N6-Methyladenosine Modification;CHEM J CHINESE U;2023
5. Interaction between N6-methyladenosine (m6A) modification and environmental chemical-induced diseases in various organ systems;Chemico-Biological Interactions;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3